Latest Expert Opinions

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
May 8, 2018

(Past Top Pick on May 16, 2017, Up 10%) Likes their 23% presence in the U.S. after expanding by buying City National a few years ago. Enjoyed a good quarter. NAFTA, housing market headwinds--who knows what'll happen? Regardless, it's a well-diversified company that'll help buffer it during an economic slowdown. She owns it partly for the U.S. presence.

Royal Bank (RY-T)
May 8, 2018

(Past Top Pick on May 16, 2017, Up 10%) Likes their 23% presence in the U.S. after expanding by buying City National a few years ago. Enjoyed a good quarter. NAFTA, housing market headwinds--who knows what'll happen? Regardless, it's a well-diversified company that'll help buffer it during an economic slowdown. She owns it partly for the U.S. presence.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$98.880
Owned
Yes
PAST TOP PICK
PAST TOP PICK
May 8, 2018

(Past Top Pick on May 16, 2017, Down 1.5%) Their pharma side and newly released drugs are doing very well which offsets their drugs that are going generic. They have a solid pipeline of 10 new drugs over the next few years, each drug expected to make $1-billion. They invest in R&D and buy companies occasionally, including one last year. Yield under 3%.

(Past Top Pick on May 16, 2017, Down 1.5%) Their pharma side and newly released drugs are doing very well which offsets their drugs that are going generic. They have a solid pipeline of 10 new drugs over the next few years, each drug expected to make $1-billion. They invest in R&D and buy companies occasionally, including one last year. Yield under 3%.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$122.610
Owned
Yes
COMMENT
COMMENT
May 8, 2018

Sold off today when Shell sold its shares. The deal was done at a 3% discount, but the whole energy patch sold off today ahead of Trump's Iran announcement. She would consider this stock. Trump pulled out of the Iran deal--but the EU didn't. Oil has had a good rally, but in Canada with the lack of pipelines (like the TransMountain deadline), she won't add much oil to her portfolio until this situation is clarified.

Sold off today when Shell sold its shares. The deal was done at a 3% discount, but the whole energy patch sold off today ahead of Trump's Iran announcement. She would consider this stock. Trump pulled out of the Iran deal--but the EU didn't. Oil has had a good rally, but in Canada with the lack of pipelines (like the TransMountain deadline), she won't add much oil to her portfolio until this situation is clarified.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$44.430
Owned
No
COMMENT
COMMENT
May 8, 2018

It's a good play on the U.S. economy. After recovering from the recession, it can increase its dividend now. Owns JP Morgan instead which is less focused on the US consumer than BAC. But it may be prudent to take some profits from BAC and buy some JP Morgan or a Canadian bank.

It's a good play on the U.S. economy. After recovering from the recession, it can increase its dividend now. Owns JP Morgan instead which is less focused on the US consumer than BAC. But it may be prudent to take some profits from BAC and buy some JP Morgan or a Canadian bank.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$29.930
Owned
No
HOLD
HOLD
May 8, 2018

Owns another company in this space. It's an alternative asset manager. They're raising money to make future investments. You want some stocks in alternative investment companies, but BX is volatile. If you own it, that's fine.

Owns another company in this space. It's an alternative asset manager. They're raising money to make future investments. You want some stocks in alternative investment companies, but BX is volatile. If you own it, that's fine.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$31.640
Owned
No
BUY
BUY
May 8, 2018

Their medical devices doing well as are their nutritional products given strong global demand; it's diversified and well-managed; pays over 2% dividend with growth. These are products we all need, and with an aging population, there will always be demand.

Their medical devices doing well as are their nutritional products given strong global demand; it's diversified and well-managed; pays over 2% dividend with growth. These are products we all need, and with an aging population, there will always be demand.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$58.710
Owned
Unknown
TOP PICK
TOP PICK
May 8, 2018

Have $280-billion under management in 4 areas: property, renewables, infrastructure and private equity. They generate stable, long-term cash flow with a strong balance sheet to buy assets opportunistically. She likes their renewable side, because that business will grow. There's a lot of runway here. (Analysts' price target $60.39)

Have $280-billion under management in 4 areas: property, renewables, infrastructure and private equity. They generate stable, long-term cash flow with a strong balance sheet to buy assets opportunistically. She likes their renewable side, because that business will grow. There's a lot of runway here. (Analysts' price target $60.39)

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management
Price
$51.310
Owned
Yes